UCB SA (EUR)
UCB
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 80.38 | 83.44 |
| 52-Wk Range | - | - |
| Last Close | 82.84 |
| Mkt Cap (m) | 15,622.22 |
| Dividend yield | 1.50 |
| ISIN | BE0003739530 |
| Volume | 95,540.00 |
| Exchange Venue | BRU |
Company Profile
UCB SA is engaged in the development of novel therapies for the treatment of central nervous system and immunological diseases.
Key Information
| Price/Earning | 19.63 |
| Price/Book | 2.22 |
| Price/Sales | 3.16 |
| P/CF | 17.58 |
| Rev Growth (3 year avg) | 5.55 |
| EPS Growth (3 year avg) | 0.15 |
| Operating Margin % | 21.84 |
| Net Margin % | 16.12 |
| Return on Equity | 11.87 |
| Debt/Equity | 0.18 |
Documents
Annual Report
| en 31/12/2019 |
Financials
Income Statement
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 3,344.00 | 3,876.00 | 4,178.00 | 4,530.00 | 4,632.00 | 4,913.00 |
| Operating Income (m) | 368.00 | 638.00 | 921.00 | 1,115.00 | 1,104.00 | 1,073.00 |
| Net Income (m) | 209.00 | 623.00 | 520.00 | 753.00 | 800.00 | 792.00 |
| Basic EPS | 1.10 | 3.25 | 2.76 | 4.00 | 4.24 | 4.23 |
| Avg. Diluted Shares Outstanding (m) | 190.46 | 192.08 | 188.37 | 188.28 | 188.48 | 187.22 |
Balance Sheet
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 2,501.00 | 2,838.00 | 2,331.00 | 2,677.00 | 2,950.00 | 3,295.00 |
| Non Current Assets (m) | 7,647.00 | 8,118.00 | 7,881.00 | 7,240.00 | 7,564.00 | 7,785.00 |
| Total Assets (m) | 10,148.00 | 10,956.00 | 10,212.00 | 9,917.00 | 10,514.00 | 11,081.00 |
| Current Liabilities (m) | 2,336.00 | 3,061.00 | 2,418.00 | 1,949.00 | 2,238.00 | 2,394.00 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 5,002.00 | 5,672.00 | 5,584.00 | 5,813.00 | 6,310.00 | 7,039.00 |
Cash Flows
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 512.00 | 245.00 | 427.00 | 927.00 | 1,089.00 | 882.00 |
| Capital Expenditure (m) | -161.00 | -146.00 | -138.00 | -209.00 | -341.00 | -294.00 |
Figures are quoted in EUR unless stated otherwise
-0.84 (-1.01%)
€
82.00
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.